Invasive Fungal Disease in Immunocompromised Children: Current and Emerging Therapies
Details
Publication Year 2024-12-01,Volume 26,Issue #12,Page 235-244
Journal Title
Current Infectious Disease Reports
Publication Type
Review
Abstract
In an era of expanding indications for iatrogenic immunosuppression, invasive fungal disease (IFD) remains a significant challenge in immunocompromised children, with case fatality rates ranging from 10 to 70%. Understanding of current recommendations and recent evidence is essential to guide optimal IFD management.
Publisher
Springer Nature
Department(s)
Infectious Diseases
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-04-24 05:44:20
Last Modified: 2025-04-24 05:45:33
An error has occurred. This application may no longer respond until reloaded. Reload 🗙